Dr Jasmin Grigg PhD MPH BPsych(Hons) is a Research Fellow in Addiction Studies at the Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences of Monash University, and Turning Point, Eastern Health. She has a research background in mental health, women’s mental health, public health and addictions treatment, with specific interest in quantitative methods and mixed-methods program evaluation. She has managed several clinical trials to improve addiction and mental health outcomes across patient and community populations. Jasmin is an Investigator on a current Australian National Health & Medical Research Council funded trial for the treatment of methamphetamine use disorder, and a VicHealth funded trial to reduce harm from alcohol among women attending breast screening services. She has led the evaluation of eight state and national public health programs, including 1800 ICE ADVICE for individuals and families affected by methamphetamine use, the NM Support national helpline for nurses and midwives, the DirectLine alcohol and drug helpline, and the Drug and Alcohol Clinical Advisory Service providing specialist support to health practitioners.

Jasmin has also undertaken translational work across patient and community populations. She was commissioned by the Victorian Department of Health and Human Services in 2018 to lead the development of the Methamphetamine Treatment Guidelines, to assist Victorian health professionals in the clinical management of methamphetamine use disorder. In her previous role at the Monash Alfred Psychiatry Research Centre, she developed training tools for general practitioners to improve response to family violence in the community, including ‘When She Talks to You about the Violence: A Toolkit for Health Practitioners in Victoria’ (2014), and contributed to the Monash/Harvard Macey Health Professional Educational Initiative, Women’s Mental Health Online Short Course for Health Practitioners (2016). In 2017, she contributed to a policy reform initiative to improve the safety of women with severe mental illness who undergo inpatient care, and also developed sex-specific algorithms to assist clinical decision-making with the goal of balancing effective psychiatric treatment while minimising the endocrine adverse effects of antipsychotic drugs. In her current role at Turning Point, Jasmin has been involved in several projects to inform alcohol and drug policy and practice change, most recently of which include a population-level evaluation of the impact of legislation on synthetic cannabinoid acute harms resulting in ambulance attendance.